Literature DB >> 3993659

The changing natural history of nephropathy in type I diabetes.

A S Krolewski, J H Warram, A R Christlieb, E J Busick, C R Kahn.   

Abstract

Events in the natural history of diabetic nephropathy (including the onset of persistent proteinuria and end-stage renal failure) were studied in a cohort of 292 patients with juvenile-onset type I diabetes who were followed for 20 to 40 years. The risk of persistent proteinuria increased rapidly between the fifth and 15th years of diabetes and declined thereafter. This pattern suggests that susceptibility to this complication was limited to a subset of patients and was exhausted over time. Patients with the most frequent severe hyperglycemia (the highest quartile) during the first 15 years of diabetes had a risk of persistent proteinuria that was four and a half times higher than that for those with the least frequent hyperglycemia (the lowest quartile). Patients whose diabetes was diagnosed in the 1930s had twice the risk of persistent proteinuria as those in whom the condition was diagnosed in later decades. Once persistent proteinuria appeared, progression to renal failure almost always followed. Half reached this stage within 10 years, and the interval for progression did not vary according to sex, frequency of hyperglycemia, or calendar year of diagnosis of diabetes. This period, however, was significantly shorter (eight versus 14 years) for patients whose diabetes was diagnosed after puberty than for those who were younger at onset. In conclusion, the development of diabetic nephropathy consists of at least two stages. The onset of proteinuria, although related to the level of exposure to hyperglycemia, appears to be influenced by genetic and/or environmental factors. The second stage, progression to renal failure, seems to be influenced by processes related to maturation or aging.

Entities:  

Mesh:

Year:  1985        PMID: 3993659     DOI: 10.1016/0002-9343(85)90284-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  164 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

3.  Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.

Authors:  C R Alleyn; L K Volkening; J Wolfson; A Rodriguez-Ventura; J R Wood; L M B Laffel
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

4.  Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.

Authors:  Masahiko Kure; Marcus G Pezzolesi; G David Poznik; Pisut Katavetin; Jan Skupien; Jonathon S Dunn; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Mol Genet Metab       Date:  2011-01-14       Impact factor: 4.797

5.  Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

Authors:  Ian H de Boer; Wanjie Sun; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Bernard Zinman
Journal:  N Engl J Med       Date:  2011-11-12       Impact factor: 91.245

Review 6.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 8.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 9.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

10.  The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Borch-Johnsen; P K Andersen; T Deckert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.